Our research not only provides partial insight into the mechanism by which Cyclin Y functions, but also suggests that targeting Cyclin Y represents a promising approach for enhancing the sensitivity of non-small cell lung cancer to radiotherapy. This evidence concerns the gene CCNY and non-small cell lung carcinoma.